SweetValueLab
Write for us

Bank of America vs JPMorgan Chase BAC vs JPM

Bank of America and JPMorgan Chase on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
BACJPM
Often compared:+ WFC+ GS

What differs most

generated from the numbers below
  • Market value: JPMorgan Chase $903.04B, Bank of America $358.24B.
  • Return on equity: JPMorgan Chase 17.4%, Bank of America 11.2%.
  • One-year price return: JPMorgan Chase +13.8%, Bank of America +1.6%.
  • Trailing P/E: JPMorgan Chase 14.5×, Bank of America 11.8×.

Price return

2025-10-16 → 2026-10-16
BAC+1.6%
JPM+13.8%
-10%0%10%20%30%2025-10-162026-04-172026-10-16
Prices at the close on 2026-10-16

Profile

latest
Sector
Financial Services
Financial Services
Industry
Banks - Diversified
Banks - Diversified
Market value
$358.24B
$903.04B
Enterprise value
$468.36B
$1.05T
Employees
211,000
320,560
Revenue per employee (TTM)
$574K
—

Our models

nightlythe valuation on each stock's page
Price vs model
1% overvalued vs model
11% overvalued vs model
Model range
$44.51–59.34
$267–356
Models in the headline
1
1
FCF growth priced in, at a 10% return
20.1%
—
Every model, its assumptions and its range: BAC valuation · JPM valuation. The growth priced in, at any return: BAC reverse DCF · JPM reverse DCF.

Trading

close 2026-10-16
Last close
$51.23
$339.72
52-week high
$64.81
$365.18
52-week low
$46.72
$282.84
Price vs 52-week high
−21.0%
−7.0%
Price vs 52-week low
+9.7%
+20.1%
Average daily volume / shares
0.5%
0.3%
Beta
1.21
1.01

Returns

to 2026-10-16
1 month
−11.5%
−2.6%
3 months
−16.7%
−1.0%
6 months
−4.3%
+9.6%
Year to date
−6.9%
+5.4%
1 year
+1.6%
+13.8%
1 year, dividends added
+3.9%
+15.9%
2 years
+19.7%
+51.9%

Valuation

price × TTM to Jun 2026
P/E (TTM)
11.8×
14.5×
P/E on consensus EPS (next FY)
11.4×
13.7×
Price / sales
3.0×
—
EV / sales
3.9×
—
EV / EBITDA
—
—
Price / book
1.2×
2.4×
Price / free cash flow (FY)
—
—
Free-cash-flow yield (FY)
—
—

Growth

TTM and FY2025
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+8.9%
+14.3%
Revenue, 3-year CAGR
6.0%
12.3%
Revenue, 5-year CAGR
5.7%
8.8%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+18.3%
+23.9%
EPS, 3-year CAGR
6.1%
18.3%
Free cash flow, 3-year CAGR
—
—
Diluted shares, 3-year change
−6.0%
−6.3%

Profitability

TTM to Jun 2026
Gross margin (FY)†
56.1%
59.9%
Operating margin
—
—
EBITDA margin
—
—
Net margin
27.8%
—
Free-cash-flow margin (FY)
—
—
Return on equity
11.2%
17.4%
Return on assets
1.0%
1.3%
Asset turnover
0.03
—
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MRQ Jun 2026
Cash
$229.75B
$309.81B
Total debt
$339.86B
$460.52B
Net debt
$110.12B
$150.71B
Debt / equity
1.1×
1.2×
Net debt / EBITDA (TTM)
—
—
Interest coverage (FY)
0.5×
0.7×
Current ratio (FY)
0.42
0.52

Dividends

trailing 12 months
Dividend yield
2.3%
1.8%
Dividends per share
$1.16
$6.15
Payout ratio (of TTM EPS)
26.7%
26.3%
Dividend per share, 5-year CAGR
9.1%
10.7%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
16
17
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$0
$1.8M
Analyst upgrades
1
0
Analyst downgrades
0
0

Statements

income TTM to Jun 2026 · cash flow FY2025
Revenue
$121.10B
—
EBITDA
—
—
Operating income
—
—
Net income
$33.66B
$65.07B
EPS (diluted)
$4.34
$23.35
Operating cash flow
$12.61B
−$147.78B
Capital expenditure
—
—
Free cash flow
—
—
Dividends paid
—
$16.63B

Keep comparing

the matchups people search for

Bank of America against

JPMorgan Chase against

Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.